Anatara Lifesciences LtdASX: ANR

Appendix 4D & Half Year Report 31 December 2025

· Issued by Anatara Lifesciences Ltd

Filed with ASX · · 24 pages · English

An explanation of the key financial elements contributing to the revenue and result above can be found in the review of operations included within the directors' report. Distributions No dividends have been paid during the financial half year. The directors do not recommend that a dividend be paid in respect of the financial half year (31 December 2024: Nil). Changes in controlled entity N/A Other

Anatara Lifesciences Ltd on 6ix

Story so far

Earlier from Anatara Lifesciences

Later from Anatara Lifesciences

All Anatara Lifesciences news releases